A federal appeals court last week declined to revisit its decision to uphold the invalidation of patents covering drug-eluting stent technology.
Pfizer
Federal Circuit again invalidates Cordis patent claims against Medtronic, Abbott, Boston Sci.
A trio of medical device giants notched another win against Johnson & Johnson(NYSE:JNJ) after a Federal Circuit judge upheld a lower court’s ruling that invalidated stent patents held by J&J subsidiary Cordis Corp.
Federal judge rules for Medtronic, Abbott, Boston Scientific over J&J in DES lawsuit
A trio of med-tech titans logged a win against Johnson & Johnson (NYSE:JNJ) in a long-running battle over drug-eluting coronary stent patents.
Chinese hackers hit Boston Scientific
Med-tech titan Boston Scientific (NYSE:BSX) was one of 760 companies hit by Chinese cyber attacks that also targeted U.S. government agencies, research universities and Internet providers.
It’s not clear whether the Natick, Mass.-based medical device maker lost any sensitive information in the attack.
Pfizer and pSivida reevaluate eye implant contracts
Pfizer offloads Capsugel to KKR for $2.4 billion
Weight loss: Does religion make you fat?
MASSDEVICE ON CALL — Regular attendance at religious activities at a young age can mean you’re twice as likely to become obese later in life, according to a study presented at an American Heart Assn. meeting.
The study by researchers at Northwestern University found that religiously observant young adults developed a higher risk of becoming obese than more secularly oriented people.
Stem cells: Athersys, Pfizer start MultiStem clinical trial for inflammatory bowel disease
Stem cell therapy developer Athersys (NSDQ:ATHX) and partner Pfizer (NYSE:PFE) have begun enrolling patients in a Phase II clinical trial for inflammatory bowel disease.
The trial marks an “important milestone” for Athersys because it’s the first time the company’s MultiStem treatment has advanced to a Phase II trial, CEO Gil Van Bokkelen said in a conference call with analysts to discuss the company’s quarterly financial numbers.
Stent Wars: Jersey judge denies Abbott/Boston Scientific move to stay stent suit
MassDevice On Call: Study shows many women skip mammograms
Study shows many women skip mammograms. Despite the uproar over mammography guideline changes, many women still skip screenings, according to a Medco Health Solutions study of utilization in more than 1.5 million women, reports MedPage Today.
Anesthesiologist gets six months for fake clinical research
A federal judge sentenced anesthesiologist Dr. Scott Reuben of Springfield, Mass., to six months in prison for fabricating pain management drug test results.